SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-007348
Filing Date
2019-04-30
Accepted
2019-04-30 06:18:37
Documents
84
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2018_biondvaxpharma.htm 20-F 2175405
2 CERTIFICATION f20f2018ex12-1_biondvax.htm EX-12.1 11957
3 CERTIFICATION f20f2018ex12-2_biondvax.htm EX-12.2 11216
4 CERTIFICATION f20f2018ex13-1_biondvax.htm EX-13.1 3958
5 CERTIFICATION f20f2018ex13-2_biondvax.htm EX-13.2 3409
6 CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M f20f2018ex15-1_biondvax.htm EX-15.1 2035
7 GRAPHIC img_001.jpg GRAPHIC 34439
8 GRAPHIC img_002.jpg GRAPHIC 6951
  Complete submission text file 0001213900-19-007348.txt   7195744

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE bvxv-20181231.xml EX-101.INS 1348829
10 XBRL SCHEMA FILE bvxv-20181231.xsd EX-101.SCH 81325
11 XBRL CALCULATION FILE bvxv-20181231_cal.xml EX-101.CAL 55047
12 XBRL DEFINITION FILE bvxv-20181231_def.xml EX-101.DEF 244795
13 XBRL LABEL FILE bvxv-20181231_lab.xml EX-101.LAB 393461
14 XBRL PRESENTATION FILE bvxv-20181231_pre.xml EX-101.PRE 298384
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-37353 | Film No.: 19778279
SIC: 2836 Biological Products, (No Diagnostic Substances)